搜尋





搜尋





BridgeBio Pharma Inc

BBIO

添加自選

66.610USD

-0.700-1.04%

收盤 09-18 16:00（美東）

13.01B總市值

虧損本益比TTM

BridgeBio Pharma Inc

66.610

-0.700-1.04%

財務摘要利潤表資產負債表現金流量表公司收入財報公司估值風險評估

概覽

新聞分析

財務

股票評分

技術分析

預測

持股情況

股息

公司資料

財務摘要利潤表資產負債表現金流量表公司收入財報公司估值風險評估

BBIO 利潤表

您可以在這裡找到BridgeBio Pharma Inc的年度或季度收入報告，以深入了解BridgeBio Pharma Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

營業總收入

120.39%243.68M

66.78%194.51M

2521.18%154.18M

4318.01%120.70M

4999.86%110.56M

-44.76%116.63M

237.08%5.88M

-33.22%2.73M

32.11%2.17M

11461.88%211.12M

-6.68%1.75M

1110.36%4.09M

-97.77%1.64M

7.79%1.83M

-85.49%1.87M

-85.58%338.00K

36.51%73.75M

266.67%1.69M

10462.30%12.89M

-71.16%2.34M

--54.02M

--462.00K

-99.12%122.00K

-69.61%8.13M

----

--13.82M

--26.74M

----

--0.00

----

營業收入

109.51%228.24M

58.63%185.01M

2431.42%148.90M

4161.42%116.42M

4924.95%108.94M

-44.76%116.63M

237.08%5.88M

-33.22%2.73M

32.11%2.17M

11461.88%211.12M

-6.68%1.75M

1110.36%4.09M

-97.77%1.64M

7.79%1.83M

-85.49%1.87M

-85.58%338.00K

36.51%73.75M

266.67%1.69M

10462.30%12.89M

-71.16%2.34M

--54.02M

--462.00K

-99.12%122.00K

-69.61%8.13M

----

--13.82M

--26.74M

----

--0.00

----

主營業務成本

311.88%15.05M

276.62%9.94M

289.01%8.11M

997.49%6.56M

510.87%3.65M

341.30%2.64M

248.49%2.08M

0.00%598.00K

-0.17%598.00K

-8.14%598.00K

-7.57%598.00K

-19.08%598.00K

-14.43%599.00K

-51.71%651.00K

-58.28%647.00K

-49.17%739.00K

542.20%700.00K

--1.35M

--1.55M

--1.45M

--109.00K

----

--0.00

--2.50M

----

--0.00

----

營業費用

43.73%350.75M

36.31%300.47M

24.38%282.61M

35.39%257.06M

39.60%244.04M

6.30%220.44M

27.36%227.22M

17.55%189.86M

21.22%174.82M

66.41%207.38M

44.56%178.41M

29.79%161.51M

-0.90%144.21M

-18.39%124.62M

-30.86%123.41M

-18.05%124.44M

-1.70%145.53M

-9.08%152.71M

39.88%178.50M

18.57%151.84M

18.84%148.04M

63.89%167.97M

38.02%127.61M

57.58%128.07M

79.88%124.57M

65.97%102.49M

40.98%92.46M

96.05%81.27M

99.09%69.25M

47.60%61.75M

--65.58M

--41.46M

--34.78M

--41.84M

研發費用

34.36%149.45M

13.65%126.64M

-10.69%116.42M

-6.29%112.87M

-3.02%111.23M

-20.96%111.43M

0.10%130.35M

-3.75%120.44M

6.70%114.69M

51.81%140.97M

43.26%130.23M

35.27%125.14M

-0.84%107.49M

-13.74%92.86M

-25.61%90.90M

-11.31%92.51M

6.32%108.40M

-12.17%107.65M

35.52%122.20M

13.31%104.31M

17.74%101.96M

79.64%122.56M

56.87%90.17M

66.52%92.05M

65.48%86.60M

59.21%68.22M

12.27%57.48M

77.47%55.28M

119.03%52.33M

26.67%42.85M

--51.20M

--31.15M

--23.89M

--33.83M

折舊攤銷及損耗

-20.05%1.05M

-7.63%1.19M

4.97%1.44M

-9.10%1.40M

-16.33%1.32M

-19.55%1.28M

-13.75%1.37M

-6.16%1.54M

-3.85%1.57M

-2.27%1.60M

-4.52%1.58M

-0.36%1.64M

3.48%1.64M

-13.32%1.63M

8.78%1.66M

--1.65M

-60.96%1.58M

--1.88M

--1.53M

----

--4.05M

----

385.71%374.00K

214.29%132.00K

330.77%112.00K

--100.00K

--77.00K

--42.00K

--26.00K

其他營業費用

---15.05M

----

營業利潤

19.77%-107.08M

-2.08%-105.96M

41.97%-128.43M

27.13%-136.36M

22.69%-133.47M

-2873.23%-103.80M

-25.29%-221.33M

-18.87%-187.13M

-21.10%-172.65M

103.05%3.74M

-45.35%-176.66M

-26.85%-157.42M

-98.62%-142.57M

18.69%-122.79M

26.61%-121.54M

16.99%-124.10M

23.65%-71.78M

9.84%-151.02M

-29.90%-165.61M

-24.65%-149.50M

24.53%-94.02M

-63.44%-167.50M

-62.12%-127.49M

-119.94%-119.94M

-79.88%-124.57M

-65.97%-102.49M

-19.91%-78.64M

-31.54%-54.53M

-99.09%-69.25M

-47.60%-61.75M

---65.58M

---41.46M

---34.78M

---41.84M

淨非營業利息收入（費用）

利息收入

70.83%6.66M

15.99%6.25M

-7.50%4.33M

89.29%6.24M

-24.97%3.90M

32.15%5.38M

-16.05%4.68M

-13.10%3.30M

15.09%5.20M

-1.88%4.08M

36.31%5.58M

56.93%3.79M

489.30%4.51M

1455.43%4.15M

2148.35%4.09M

932.91%2.42M

137.15%766.00K

-32.23%267.00K

-59.38%182.00K

-66.18%234.00K

-65.42%323.00K

-79.70%394.00K

-81.41%448.00K

-74.71%692.00K

-43.80%934.00K

-7.88%1.94M

63.61%2.41M

418.18%2.74M

83000.00%1.66M

210600.00%2.11M

--1.47M

--528.00K

--2.00K

--1.00K

利息費用

45.13%54.62M

25.33%52.81M

68.72%50.31M

108.79%48.15M

64.09%37.64M

79.54%42.14M

47.13%29.82M

13.57%23.06M

11.38%22.94M

16.65%23.47M

1.39%20.27M

2.43%20.31M

1.55%20.59M

-1.10%20.12M

32.09%19.99M

79.14%19.82M

87.09%20.28M

108.91%20.34M

38.06%15.13M

1.26%11.07M

0.79%10.84M

142.84%9.74M

260.59%10.96M

417.23%10.93M

454.04%10.75M

139.98%4.01M

157.85%3.04M

82.79%2.11M

846.83%1.94M

23771.43%1.67M

--1.18M

--1.16M

--205.00K

--7.00K

出售證券收益

----

-100.00%0.00

100.00%0.00

-100.00%0.00

743.98%8.14M

--21.27M

---5.35M

-98.67%1.44M

--964.00K

--0.00

--107.95M

----

股權收益

68.13%-6.43M

-17.53%-18.28M

-25.96%-21.03M

-141.26%-15.83M

-154.75%-20.19M

---15.56M

---16.70M

---6.56M

---7.92M

----

-1618.18%-4.72M

---6.59M

---4.96M

---4.60M

---275.00K

--0.00

特殊收入（費用）

100.00%0.00

-137.18%-11.13M

-118.65%-8.84M

-100.65%-805.00K

27.56%-21.73M

-522.41%-4.69M

17528.68%47.41M

3594.85%123.40M

-790.18%-29.99M

90.20%-754.00K

94.58%-272.00K

57.94%-3.53M

85.13%-3.37M

---7.69M

---5.02M

---8.40M

---22.66M

----

-100.00%0.00

---416.00K

--0.00

---2.00M

--19.33M

--0.00

----

其他非經營性收入（費用）

-14.68%5.59M

-48.33%4.25M

627.71%11.82M

816.03%16.46M

1136.08%6.55M

511.06%8.23M

216.57%1.62M

2582.09%1.80M

-1641.46%-632.00K

186.07%1.35M

-88.75%513.00K

-98.94%67.00K

100.38%41.00K

79.34%-1.56M

-83.88%4.56M

1025.58%6.33M

-540.21%-10.82M

-231.37%-7.58M

849.76%28.28M

-7700.00%-684.00K

234.48%2.46M

1116.46%5.77M

1984.81%2.98M

-96.40%9.00K

-934.25%-1.83M

131.16%474.00K

94.74%-158.00K

4066.67%250.00K

130.59%219.00K

-159.56%-1.52M

---3.00M

--6.00K

---716.00K

---586.00K

稅前利潤

14.18%-155.89M

1.80%-166.56M

26.85%-194.75M

-13.53%-186.48M

-140.47%-181.66M

-369.05%-169.61M

-56.31%-266.24M

8.49%-164.25M

52.99%-75.54M

74.67%-36.16M

-21.17%-170.33M

-28.03%-179.49M

-6179.91%-160.70M

29.11%-142.73M

7.69%-140.57M

12.93%-140.19M

97.49%-2.56M

-17.68%-201.33M

-12.78%-152.28M

-23.70%-161.02M

25.06%-102.07M

-64.37%-171.08M

-60.46%-135.03M

-114.57%-130.17M

-83.42%-136.21M

-49.90%-104.08M

-70.90%-84.15M

-44.17%-60.66M

-108.01%-74.27M

-63.65%-69.44M

---49.24M

---42.08M

---35.70M

---42.43M

所得稅

-100.00%0.00

----

-110.41%-120.00K

---1.54M

--2.10M

--0.00

--1.15M

----

除稅後利潤

15.17%-155.89M

1.80%-166.56M

27.21%-194.63M

-12.59%-184.94M

-143.25%-183.76M

-369.05%-169.61M

-56.98%-267.39M

8.49%-164.25M

52.99%-75.54M

74.67%-36.16M

-21.17%-170.33M

-28.03%-179.49M

-6179.91%-160.70M

29.11%-142.73M

7.69%-140.57M

12.93%-140.19M

97.49%-2.56M

-17.68%-201.33M

-12.78%-152.28M

-23.70%-161.02M

25.06%-102.07M

-64.37%-171.08M

-60.46%-135.03M

-114.57%-130.17M

-83.42%-136.21M

-49.90%-104.08M

-70.90%-84.15M

-44.17%-60.66M

-108.01%-74.27M

-63.65%-69.44M

---49.24M

---42.08M

---35.70M

---42.43M

持續經營利潤

15.17%-155.89M

1.80%-166.56M

27.21%-194.63M

-12.59%-184.94M

-143.25%-183.76M

-369.05%-169.61M

-56.98%-267.39M

8.49%-164.25M

52.99%-75.54M

74.67%-36.16M

-21.17%-170.33M

-28.03%-179.49M

-6179.91%-160.70M

29.11%-142.73M

7.69%-140.57M

12.93%-140.19M

97.49%-2.56M

-17.68%-201.33M

-12.78%-152.28M

-23.70%-161.02M

25.06%-102.07M

-64.37%-171.08M

-60.46%-135.03M

-114.57%-130.17M

-83.42%-136.21M

-49.90%-104.08M

-70.90%-84.15M

-44.17%-60.66M

-108.01%-74.27M

-63.65%-69.44M

---49.24M

---42.08M

---35.70M

---42.43M

歸屬少數股東的淨利潤

-98.11%-3.67M

-14.91%-2.51M

24.24%-1.77M

0.90%-2.19M

11.16%-1.85M

-131.57%-2.19M

-7.29%-2.34M

11.05%-2.21M

25.53%-2.09M

63.35%-944.00K

26.82%-2.18M

12.79%-2.49M

-138.43%-2.80M

47.78%-2.58M

41.65%-2.98M

43.83%-2.85M

227.44%7.30M

38.36%-4.93M

66.07%-5.11M

64.49%-5.08M

62.28%-5.73M

34.57%-8.00M

-40.69%-15.04M

-1991.81%-14.31M

-81.36%-15.18M

-48.25%-12.23M

-0.88%-10.69M

93.59%-684.00K

8.53%-8.37M

-364.37%-8.25M

---10.60M

---10.68M

---9.15M

--3.12M

歸属于母公司的淨利潤

16.32%-152.22M

2.02%-164.04M

27.24%-192.86M

-12.78%-182.74M

-147.64%-181.90M

-375.41%-167.42M

-57.63%-265.05M

8.45%-162.04M

53.48%-73.46M

74.87%-35.22M

-22.21%-168.15M

-28.88%-177.00M

-1502.06%-157.90M

28.64%-140.16M

6.51%-137.59M

11.93%-137.34M

89.77%-9.86M

-20.43%-196.40M

-22.67%-147.18M

-34.59%-155.94M

20.40%-96.35M

-77.55%-163.08M

-63.33%-119.98M

-93.16%-115.86M

-83.68%-121.03M

-50.12%-91.85M

-90.10%-73.46M

-91.01%-59.98M

-116.72%-65.89M

-64.14%-61.19M

---38.64M

---31.40M

---30.41M

---37.28M

歸屬普通股東的淨利潤

16.32%-152.22M

2.02%-164.04M

27.24%-192.86M

-12.78%-182.74M

-147.64%-181.90M

-375.41%-167.42M

-57.63%-265.05M

8.45%-162.04M

53.48%-73.46M

74.87%-35.22M

-22.21%-168.15M

-28.88%-177.00M

-1502.06%-157.90M

28.64%-140.16M

6.51%-137.59M

11.93%-137.34M

89.77%-9.86M

-20.43%-196.40M

-22.67%-147.18M

-34.59%-155.94M

20.40%-96.35M

-77.55%-163.08M

-63.33%-119.98M

-93.16%-115.86M

-83.68%-121.03M

-50.12%-91.85M

-90.10%-73.46M

-91.01%-59.98M

-116.72%-65.89M

-64.14%-61.19M

---38.64M

---31.40M

---30.41M

---37.28M

基本每股收益

18.57%-0.78

4.36%-0.84

28.78%-1.00

-10.81%-0.95

-143.83%-0.95

-346.82%-0.88

-45.17%-1.40

20.69%-0.86

60.19%-0.39

78.54%-0.20

-4.61%-0.96

-16.75%-1.08

-1363.88%-0.98

31.80%-0.92

9.06%-0.92

12.68%-0.93

89.77%-0.07

-14.44%-1.35

-0.46%-1.01

-8.44%-1.06

36.53%-0.66

-50.88%-1.18

-61.74%-1.01

-91.37%-0.98

-80.52%-1.03

-46.55%-0.78

-85.54%-0.62

-87.64%-0.51

-116.73%-0.57

-64.13%-0.53

---0.34

---0.27

---0.26

---0.32

稀釋每股收益

18.57%-0.78

4.36%-0.84

28.78%-1.00

-10.81%-0.95

-143.83%-0.95

-346.82%-0.88

-45.17%-1.40

20.69%-0.86

60.19%-0.39

78.54%-0.20

-4.61%-0.96

-16.75%-1.08

-1363.88%-0.98

31.80%-0.92

9.06%-0.92

12.68%-0.93

89.77%-0.07

-14.44%-1.35

-0.46%-1.01

-8.44%-1.06

36.53%-0.66

-50.88%-1.18

-61.74%-1.01

-91.37%-0.98

-80.52%-1.03

-46.55%-0.78

-85.54%-0.62

-87.64%-0.51

-116.73%-0.57

-64.13%-0.53

---0.34

---0.27

---0.26

---0.32

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 BridgeBio Pharma Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 BBIO 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

BridgeBio Pharma Inc 財年末的營收是多少？



BridgeBio Pharma Inc 2025 財年營收為 502.08M，高於上一財年的 221.90M。

BridgeBio Pharma Inc 最近一個季度的營收是多少？



BridgeBio Pharma Inc 最近一個季度的營收為 243.68M，同比增長 120.39%。

BridgeBio Pharma Inc 全年的淨利潤是多少？



BridgeBio Pharma Inc 2025 財年淨利潤為 -724.93M。

BridgeBio Pharma Inc 上一季度的淨利潤是多少？



BridgeBio Pharma Inc 最近一個季度的淨利潤為 -152.22M。

BridgeBio Pharma Inc 年度營業利潤是多少？



BridgeBio Pharma Inc 2025 財年的營業利潤為 -502.06M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。